EcoDrugPlus

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCSEG00000021077
Gene Symbol: NPY2R
1 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSCSEG00000009235
Gene Symbol: NPY4R
1 Cross references
137 Possible Orthologues:

Neuropeptide Y Receptor Type 2

Ensembl ID : ENSCSEG00000005540
Gene Symbol: LOC103389603
3 Cross references
177 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCSEG00000003659
Gene Symbol: NTSR1
3 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSCSEG00000014262
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCSEG00000012494
Gene Symbol: NTRK2
1 Cross references
195 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCSEG00000011619
Gene Symbol: NTRK2
1 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSCSEG00000001381
Gene Symbol: NTRK3
2 Cross references
144 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSCSEG00000010626
Gene Symbol: NTRK3
3 Cross references
203 Possible Orthologues:

Neutrophil Collagenase-Like

Ensembl ID : ENSCSEG00000012515
Gene Symbol: LOC103394799
2 Cross references
173 Possible Orthologues:

Nicastrin

Ensembl ID : ENSCSEG00000021323
Gene Symbol: NCSTN
4 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSCSEG00000010306
Gene Symbol: NAMPT
3 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).